Ergéa Group strengthens its Senior Team with Head of Supplier Relationships and Head of International Projects

Ergéa Group strengthens its Senior Team with Head of Supplier Relationships and Head of International Projects

Ergéa Group, a prominent platform for cancer care, diagnostic imaging, and medical technology services across Europe, is pleased to announce the appointment of two key positions in its senior team. Brendan Loughran joins Ergéa Group as Head of Supplier Relationships, and Jason Long takes on the role of Head of International projects at Ergéa Group. […]

Nick Clare_Vendor Strategy Work Group Lead_ELRIG UK

ELRIG UK Appoints Nick Clare to Board as Vendor Strategy Work Group Lead

The European Laboratory Research & Innovation Group (ELRIG) UK today announced the appointment of Nick Clare to the ELRIG board. He will chair and lead the Vendor Strategy Work Group to help ensure the vendors’ perspectives and interests are represented within the ELRIG board.

Siemens Healthineers Enters into Agreement with Scopio Labs to Distribute Full-Field Digital Cell Morphology Technology

Siemens Healthineers Enters into Agreement with Scopio Labs to Distribute Full-Field Digital Cell Morphology Technology

The alliance between Siemens Healthineers and Scopio Labs will revolutionize the way laboratorians view patient samples—from under a microscope to digitized slides. Scopio Labs has granted to Siemens Healthineers global rights to distribute the Scopio X100 and Scopio X100HT, digital solutions that offer full-field imaging and an AI-powered Decision Support System with remote viewing capabilities. […]

SHL medical

SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector

SHL Medical, a world-leading provider of advanced drug delivery solutions, announced that it has signed a collaboration agreement with MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, to develop an autoinjector for clinical and potential commercial supply of MoonLake’s Nanobody® sonelokimab based on SHL Medical’s Molly® autoinjector technology.

nanologica

Nanologica’s Product within Preparative Chromatography Reaches Quality Requirements

After successfully implementing fine-tuning in production, Nanologica’s product now meets the company’s own requirements for quality in all evaluated parameters.

image001

Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment

Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in cyno samples

Tetra Pharm Technologies launches first product in Germany

Tetra Pharm Technologies launches first product in Germany

The Danish biotech company, Tetra Pharm Technologies, is launching its first product, XATEPA®, on the German market. XATEPA® is a pain-relieving pharmaceutical drug based on cannabinoids.

Robert (Bobbie) Dressen, CEO of Medical Alley, and Brigit van Dijk – van de Reijt, CEO of the Brabant Development Agency (BOM), on behalf of ROM NL, signed a Memorandum of Understanding (MOU) in the presence of Minister Kuipers of Health, Welfare and Sport.

Minnesota and Regional Development Agencies in the Netherlands collaborate to further develop the medical technology ecosystems

Robert (Bobbie) Dressen, CEO of Medical Alley, and Brigit van Dijk – van de Reijt, CEO of the Brabant Development Agency (BOM), on behalf of ROM NL, signed a Memorandum of Understanding (MOU) in the presence of Minister Kuipers of Health, Welfare and Sport.

Ziathpr56 image

RFID tagging technology streamlines cryogenic sample management

Ziath, a Azenta Life Sciences company, announce a revolution in cryogenic sample management – the Ri-Track Mirage 2D barcoded tube whole rack reader.

MammaTyper Kits

Sysmex Europe SE has signed a multi-market EMEA distribution agreement with Cerca Biotech, the company behind the innovative breast cancer diagnostic assay – MammaTyper®

As a result of the agreement, MammaTyper® will become part of the Sysmex Life Science portfolio in 13 territories across EMEA, including the UK, Ireland and the majority of mainland Europe.